Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell signaling. Its structure supports binding to ATP sites in enzymes, making it valuable in developing anticancer and anti-inflammatory agents. The compound's rigid heterocyclic core and fluorinated group enhance metabolic stability and bioavailability, which are favorable traits in drug design. Also explored in medicinal chemistry for optimizing lead compounds due to its favorable physicochemical properties and ability to improve target selectivity.